Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Global Nocturia Market to Grow at 7.5% CAGR to Reach US$ 2.5 Bn by 2026

Press release Description

Albany, New York, March 28, 2018: A new comprehensive study titled “Global Market Study on Nocturia: Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period” has recently been added to the database of Market Research Reports Search Engine (MRRSE). According to the report, the global nocturia market is likely to grow at 7.5% CAGR during the assessment period, and reach nearly US$ 2.5 Bn by the end of the forecast period.

The report offers a detailed analysis on the global nocturia market, highlighting the strategies of key companies operating in the market. The detailed competitive landscape included in the report offers thorough analysis on the business and product strategies of some of the leading players. The report also includes a detailed qualitative analysis on the key factors driving and impeding the market. Overall, the report can be a valuable source of guidance and reference for key players looking to consolidate and make a foray into the market.

The report segments the global nocturia market into distribution channel, drug type, indication and region. The distribution channel segment is further sub-segmented into online pharmacies, drug stores, retail pharmacies and hospital pharmacies. The drug type segment is categorized into antispasmodic, antibiotics, desmopressin, anticholinergic drugs and others. Geographically, the market is divided into key regions globally which are North America, Latin America, Europe, Asia Pacific Excluding Japan and Middle East & Africa.

By indication type, low nocturnal bladder capacity segment is likely to grow at the fastest CAGR during the assessment period. The report projects the low nocturnal bladder capacity segment to grow at 7.8% CAGR during the assessment period. By drug type, desmopressin is likely to account for the largest revenue share of the market. By distribution channel, hospital pharmacies are likely to remain a dominant channel in the market, whereas online pharmacies are projected to grow at a high CAGR during the assessment period.

North America is likely to remain one of the largest markets for nocturia market globally. The adoption of nocturia in North America is driven by growing awareness and investment in health and well-being. On account of these factors, the North American nocturia market is likely to grow at a steady pace during the assessment period.

The report profiles some of the leading players operating in the market. Some of these players are Avadel Pharmaceuticals plc, Teva Pharmaceutical Industries Ltd., AA Pharma Inc., Glenmark Pharmaceuticals Inc., Urigen Pharmaceuticals, Ferring Pharmaceuticals and Allergan, Inc. These players are focusing on developing innovative products to consolidate their position in the market.

Browse Full Global Nocturia Market Report with TOC :

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.


State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559